Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AYS

SARS-CoV-2 non-structural protein-1 (nsp1) in complex with 4-(2-aminothiazol-4-yl)phenol

8AYS の概要
エントリーDOI10.2210/pdb8ays/pdb
関連するPDBエントリー8A55
分子名称Host translation inhibitor nsp1, 4-(2-amino-1,3-thiazol-4-yl)phenol (3 entities in total)
機能のキーワードsars-cov-2, non-structural protein-1, fragment hit, complex, viral protein
由来する生物種Severe acute respiratory syndrome coronavirus 2
タンパク質・核酸の鎖数1
化学式量合計13170.20
構造登録者
Ma, S.,Damfo, S.,Pinotsis, N.,Bowler, M.W.,Kozielski, F. (登録日: 2022-09-03, 公開日: 2022-11-23, 最終更新日: 2024-02-07)
主引用文献Ma, S.,Damfo, S.,Lou, J.,Pinotsis, N.,Bowler, M.W.,Haider, S.,Kozielski, F.
Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
Int J Mol Sci, 23:-, 2022
Cited by
PubMed Abstract: The regular reappearance of coronavirus (CoV) outbreaks over the past 20 years has caused significant health consequences and financial burdens worldwide. The most recent and still ongoing novel CoV pandemic, caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has brought a range of devastating consequences. Due to the exceptionally fast development of vaccines, the mortality rate of the virus has been curbed to a significant extent. However, the limitations of vaccination efficiency and applicability, coupled with the still high infection rate, emphasise the urgent need for discovering safe and effective antivirals against SARS-CoV-2 by suppressing its replication or attenuating its virulence. Non-structural protein 1 (nsp1), a unique viral and conserved leader protein, is a crucial virulence factor for causing host mRNA degradation, suppressing interferon (IFN) expression and host antiviral signalling pathways. In view of the essential role of nsp1 in the CoV life cycle, it is regarded as an exploitable target for antiviral drug discovery. Here, we report a variety of fragment hits against the N-terminal domain of SARS-CoV-2 nsp1 identified by fragment-based screening via X-ray crystallography. We also determined the structure of nsp1 at atomic resolution (0.99 Å). Binding affinities of hits against nsp1 and potential stabilisation were determined by orthogonal biophysical assays such as microscale thermophoresis and thermal shift assays. We identified two ligand-binding sites on nsp1, one deep and one shallow pocket, which are not conserved between the three medically relevant SARS, SARS-CoV-2 and MERS coronaviruses. Our study provides an excellent starting point for the development of more potent nsp1-targeting inhibitors and functional studies on SARS-CoV-2 nsp1.
PubMed: 36293303
DOI: 10.3390/ijms232012448
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.37 Å)
構造検証レポート
Validation report summary of 8ays
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon